Designing ligands to bind proteins
- PMID: 16817982
- PMCID: PMC2712650
- DOI: 10.1017/S0033583506004240
Designing ligands to bind proteins
Abstract
The ability to design drugs (so-called 'rational drug design') has been one of the long-term objectives of chemistry for 50 years. It is an exceptionally difficult problem, and many of its parts lie outside the expertise of chemistry. The much more limited problem - how to design tight-binding ligands (rational ligand design) - would seem to be one that chemistry could solve, but has also proved remarkably recalcitrant. The question is 'Why is it so difficult?' and the answer is 'We still don't entirely know'. This perspective discusses some of the technical issues - potential functions, protein plasticity, enthalpy/entropy compensation, and others - that contribute, and suggests areas where fundamental understanding of protein-ligand interactions falls short of what is needed. It surveys recent technological developments (in particular, isothermal titration calorimetry) that will, hopefully, make now the time for serious progress in this area. It concludes with the calorimetric examination of the association of a series of systematically varied ligands with a model protein. The counterintuitive thermodynamic results observed serve to illustrate that, even in relatively simple systems, understanding protein-ligand association is challenging.
Figures
References
-
- Benkovic SJ, Hammes-Schiffer S. A perspective on enzyme catalysis. Science. 2003;301:1196–1202. - PubMed
-
- Boriack PA, Christianson DW, Kingery-Wood J, Whitesides GM. Secondary interactions significantly removed from the sulfonamide binding pocket of carbonic anhydrase II influence binding constants. Journal of Medicinal Chemistry. 1995;38:2286–2291. - PubMed
-
- Cappalonga Bunn AM, Alexander RS, Christianson DW. Mapping protein-peptide affinity: binding of peptidylsulfonamide inhibitors to human carbonic anhydrase II. Journal of the American Chemical Society. 1994;116:5063–5068.
-
- Carlson HA. Protein flexibility and drug design: how to hit a moving target. Current Opinion in Chemical Biology. 2002;6:447–452. - PubMed
-
- Chandler D. Two faces of water. Nature. 2002;417:491. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
